Evidence map›Paper›PMID 36800165›Full record

ReviewPulmonary therapy2023

Surgical and Device Interventions in the Treatment of Chronic Thromboembolic Disease.

Hayah Kassis-George, Candice Lee, Mithun Chakravarthy, Manreet Kanwar

Open access · goldAbstract readReview
In one paragraph

Review in Pulmonary therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hayah Kassis-GeorgeDivision of Heart Failure and Pulmonary Hypertension, Cardiovascular Institute, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-4171-5451
Candice LeeDivision of Cardiothoracic Surgery, Cardiovascular Institute, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, PA, USA.
Mithun ChakravarthyDivision of Cardiology, Cardiovascular Institute, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, PA, USA.
Manreet KanwarDivision of Heart Failure and Pulmonary Hypertension, Cardiovascular Institute, Allegheny Health Network, Allegheny General Hospital, Pittsburgh, PA, USA. Manreet.kanwar@ahn.org.
Allegheny Health Network · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic thromboembolic pulmonary disease (CTEPD) is characterized by unresolved clot burden in large pulmonary arteries, obstructive disease in smaller arteries, and increased downstream clot burden. This occurs in the setting of abnormal fibrinolysis or hematological disorders. Up to 50% of patients in some studies are unaware of a self-history of a deep venous thrombosis or pulmonary embolism. Ultimately, they present with symptoms of pulmonary hypertension (PH), which can result in right heart failure (RHF). Pulmonary endarterectomy (PEA) is curative, though many patients have prohibitive surgical risk or surgically inaccessible disease, warranting other interventions such as balloon pulmonary angioplasty (BPA) and medical therapy. Rarely, other treatment options may be implemented. We focus this review on PEA and BPA, with an overview of the history of CTEPD and the evolution of these procedures. We will briefly discuss other treatment modalities.

Indexed as

Balloon pulmonary angioplastyChronic thromboembolic pulmonary diseaseChronic thromboembolic pulmonary hypertensionPotts ShuntPulmonary artery denervationPulmonary endarterectomyPulmonary hypertension

Identifiers

PMID36800165
PMCPMC10203076
OpenAlexW4321165588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.